SCHEMBL7366178

SCHEMBL7366178

Cn1c(=O)cc(C(=O)OCc2ccccc2)[nH]c1=O

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 9/20 0.55
MMP2 P08253 8/20 0.55
MMP12 P39900 8/20 0.55
MMP9 P14780 8/20 0.55
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 1/20 0.43
STAT1 P42224 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7442587 0.84 MMP2 (0.55) MMP1MMP2MMP12MMP9SMN1; SMN2
SCHEMBL7369379 0.74 KMT2A (0.67) MMP1MMP2MMP12MMP9SLC6A2
SCHEMBL6256905 0.74 AKR1B1 (0.48) MMP1MMP2MMP12MMP9SMN1; SMN2
SCHEMBL6735485 0.73 LGMN (0.48) MMP1MMP2MMP12MMP9SMN1; SMN2
SCHEMBL7121166 0.73 MAT2A (0.51) MMP1MMP2MMP12MMP9SMN1; SMN2
SCHEMBL6237834 0.72 HSD17B10 (0.45) MMP1MMP2MMP12MMP9SLC6A2
SCHEMBL3964905 0.71 IDO1 (0.61) MMP1MMP2MMP12MMP9TP53
SCHEMBL30741601 0.71 IDO1 (0.61) MMP1MMP2MMP12MMP9TP53
SCHEMBL7651783 0.71 RAB9A (0.46) MMP1MMP2MMP12MMP9SMN1; SMN2
SCHEMBL27391742 0.71 MMP2 (0.63) MMP1MMP2MMP12MMP9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4665056-A CENTRAL NERVOUS SYSTEM DISORDERS TANABE SEIYAKU CO., LTD. (JP) 1987-05-12 US disclosed
EP-0168042-A2 Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them TANABE SEIYAKU CO., LTD. (JP) 1986-01-15 EP disclosed